Journey Medical Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
DERM Nasdaq 2834 journeymedicalcorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Journey Medical Corporation

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2025 10:15 pm
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - May 7th, 2025 8:01 pm
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? - May 5th, 2025 1:57 pm
Why Journey Medical Corporation (DERM) is Surging in 2025 - Apr 30th, 2025 9:25 am
Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last? - Apr 23rd, 2025 11:00 am
Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now? - Apr 18th, 2025 9:46 pm
Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains? - Apr 7th, 2025 1:17 pm
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer - Apr 1st, 2025 8:01 pm
Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Mar 28th, 2025 11:23 am
Q4 2024 Journey Medical Corp Earnings Call - Mar 27th, 2025 12:25 pm
Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ... - Mar 27th, 2025 7:02 am
Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates - Mar 26th, 2025 9:15 pm
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - Mar 26th, 2025 8:01 pm
Journey Medical launches Emrosi for the treatment of rosacea - Mar 25th, 2025 12:50 pm
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea - Mar 24th, 2025 12:30 pm
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - Mar 19th, 2025 8:01 pm
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference - Mar 12th, 2025 12:30 pm
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea - Mar 5th, 2025 9:01 pm
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida - Mar 4th, 2025 9:01 pm
Journey Medical Corporation (DERM): A Bull Case Theory - Feb 20th, 2025 7:38 pm